Research location
Garran
Australian Capital Territory, Australia
Advertisement
Research activity in Garran
Australian Capital Territory, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 54 trials and 54 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Garran
54 linked trials · page 1 of 2BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)NCT07625644 · 2026-08-04 · 1 site observation
RECRUITING
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerNCT07155187 · 2025-12-10 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
Working Out M0 Bipolar Androgen TherapyNCT06594926 · 2024-08-14 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailureNCT06424288 · 2024-06-17 · 1 site observation
RECRUITING
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT06236438 · 2024-04-10 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)NCT06940154 · 2025-08-12 · 1 site observation
COMPLETED
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)NCT06940141 · 2025-08-08 · 1 site observation
COMPLETED
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationNCT05636176 · 2023-05-08 · 1 site observation
TERMINATED
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecNCT05352815 · 2022-06-01 · 1 site observation
COMPLETED
EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCNCT05075577 · 2021-12-21 · 1 site observation
TERMINATED
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityNCT04788511 · 2021-03-16 · 1 site observation
COMPLETED
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaNCT04334759 · 2021-02-18 · 1 site observation
COMPLETED
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.NCT03448406 · 2018-03-20 · 1 site observation
COMPLETED
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure SymptomsNCT03448419 · 2018-03-20 · 1 site observation
COMPLETED
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade PatientsNCT02922036 · 2018-01-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)NCT03260894 · 2017-12-07 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.NCT01320345 · 2016-11-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)NCT02477826 · 2015-08-05 · 1 site observation
COMPLETED
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerNCT02003924 · 2013-10-31 · 1 site observation
COMPLETED
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)NCT01881230 · 2013-09-26 · 1 site observation
COMPLETED
An Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01885078 · 2013-06-27 · 1 site observation
COMPLETED
Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT03176238 · 2013-03-29 · 1 site observation
COMPLETED
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate CancerNCT01578655 · 2012-08-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast CancerNCT01234337 · 2011-02-21 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.NCT01098539 · 2010-05-01 · 1 site observation
COMPLETED
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.NCT01128894 · 2010-05-01 · 1 site observation
COMPLETED
Asthma Exacerbation StudyNCT01086384 · 2010-02-22 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational StudyNCT00949286 · 2010-01-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01009463 · 2009-09-25 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusNCT00856284 · 2009-03-01 · 1 site observation
COMPLETED
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01 · 1 site observation
COMPLETED
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation
COMPLETED
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaNCT00640601 · 2008-03-01 · 1 site observation
COMPLETED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Enzastaurin in Combination of Capecitabine to Treat Breast CancerNCT00437294 · 2007-03-01 · 1 site observation
TERMINATED
A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat InhalerNCT02172560 · 2007-03-01 · 1 site observation
COMPLETED
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic PatientsNCT00391196 · 2006-11-01 · 1 site observation
TERMINATED
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerNCT00248170 · 2005-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.